» Articles » PMID: 2738163

Proposals for the Classification of Chronic (mature) B and T Lymphoid Leukaemias. French-American-British (FAB) Cooperative Group

Overview
Journal J Clin Pathol
Specialty Pathology
Date 1989 Jun 1
PMID 2738163
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Peripheral blood, bone marrow films, and bone marrow biopsy specimens from 110 patients, well characterised by clinical and laboratory studies, including electron microscopy, were reviewed, to determine proposals for the classification of chronic (mature) B and T cell leukaemias. On the basis of cytology and membrane phenotype the following disorders were defined: (i) B cell type: chronic lymphocytic leukaemia (CLL); CLL of mixed cell type, which includes cases with more than 10% and less than 55% prolymphocytes (CLL/PL), and a less well defined form with pleomorphic lymphocytes but less than 10% prolymphocytes; prolymphocytic leukaemia (PLL); hairy cell leukaemia (HCL); HCL variant; splenic lymphoma with circulating villous lymphocytes; leukaemic phase of non-Hodgkin's lymphoma (follicular lymphoma, intermediate, or mantle zone lymphoma and others); lymphoplasmacytic lymphoma with peripheral blood disease (mostly Waldenström's macroglobulinaemia); and plasma cell leukaemia. (ii) T cell type: T/CLL, which was differentiated from reactive T/lymphocytosis; T/PLL; adult T cell leukaemia/lymphoma; and Sézary's syndrome. The recognition of distinct entities within the B and T cell leukaemias seems to have clinical and epidemiological connotations. It is hoped that these proposals may serve as the basis for further work, discussion, and improved management of patients.

Citing Articles

What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study.

DArena G, Vitale C, Pietrantuono G, Villani O, Mansueto G, DAuria F Cancers (Basel). 2024; 16(2).

PMID: 38275909 PMC: 10814247. DOI: 10.3390/cancers16020469.


An effective treatment and suspicious adverse reaction to Ibrutinib in a patient diagnosed with splenic B-cell lymphoma/leukaemia with prominent nucleoli: A first case report.

Shen M, Li F, Luo X, Wang Z Medicine (Baltimore). 2024; 102(52):e36022.

PMID: 38206706 PMC: 10754594. DOI: 10.1097/MD.0000000000036022.


Joint representation and visualization of derailed cell states with Decipher.

Nazaret A, Fan J, Lavallee V, Burdziak C, Cornish A, Kiseliovas V bioRxiv. 2023; .

PMID: 38014231 PMC: 10680623. DOI: 10.1101/2023.11.11.566719.


Atypical Chronic Lymphocytic Leukemia-The Current Status.

Robak T, Krawczynska A, Cebula-Obrzut B, Urbaniak M, Iskierka-Jazdzewska E, Robak P Cancers (Basel). 2023; 15(18).

PMID: 37760396 PMC: 10527541. DOI: 10.3390/cancers15184427.


B-Cell Prolymphocytic Leukemia.

Menakuru S, Roepke J, Siddiqui S J Hematol. 2023; 12(2):82-86.

PMID: 37187496 PMC: 10181324. DOI: 10.14740/jh1096.


References
1.
Minden M, Mak T . The structure of the T cell antigen receptor genes in normal and malignant T cells. Blood. 1986; 68(2):327-36. View

2.
Melo J, Catovsky D, GALTON D . The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol. 1986; 63(2):377-87. View

3.
Bennett J, Cain K, Glick J, Johnson G, Ezdinli E, Oconnell M . The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience. J Clin Oncol. 1986; 4(10):1462-9. DOI: 10.1200/JCO.1986.4.10.1462. View

4.
Melo J, Wardle J, Chetty M, England J, Lewis S, GALTON D . The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. III. Evaluation of cell size by morphology and volume measurements. Br J Haematol. 1986; 64(3):469-78. DOI: 10.1111/j.1365-2141.1986.tb02202.x. View

5.
Koduru P, Filippa D, Richardson M, Jhanwar S, Chaganti S, Koziner B . Cytogenetic and histologic correlations in malignant lymphoma. Blood. 1987; 69(1):97-102. View